Compare ACADIA Pharmaceuticals Inc. (ACAD) vs CSX Corporation (CSX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ACADIA Pharmaceuticals Inc. vs CSX Corporation — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.55 (market cap $5.07B), while CSX Corporation trades at $50.06 (market cap $92.55B). The key difference: CSX Corporation is far larger — about 18.3× ACADIA Pharmaceuticals Inc.'s market cap, and CSX Corporation pays a 1.12% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | CSX | |
|---|---|---|
Market Cap | $5.07B | $92.55B |
Sector | Health | Industrials |
52-Week High | $29.41 | $53.21 |
52-Week Low | $20.06 | $32.05 |
Enterprise Value | $4.19B | $110.52B |
Dividend Yield | — | 1.12% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →About CSX Corporation
Operating in the Eastern United States, Class I railroad CSX generated revenue near $12.5 billion in 2021. On its more than 21,000 miles of track, CSX hauls shipments of coal (13% of consolidated revenue), chemicals (22%), intermodal containers (16%), automotive cargo (9%), and a diverse mix of other bulk and industrial merchandise.
Read more on CSX →
